Our Leaders
Meet Our Leaders
Mark Thierer
Chief Executive Officer
Mark Thierer is a lifelong leader in the healthcare space with more than 30 years of experience leading organizations to financial and operational success in the healthcare system. As Chief Executive Officer, he leads EVERSANA’s vision to accelerate the industry’s shift to patient-centered, value-based care – creating a healthier world for all. He is also the founder of Waltz Health with his son, Jonathon Thierer, which merged with EVERSANA in August 2025.
Most recently Mark served as CEO of OptumRx, overseeing all Optum pharmacy care services, including the management of pharmacy benefits, pharmacy network, homedelivery pharmacy and specialty pharmacy programs. Prior to OptumRx, Mark served as the Chairman of the Board and CEO of Catamaran (NASDAQ: CTRX), one of the nation’s largest pharmacy benefit management companies serving 35 million lives. Catamaran was acquired by United Healthcare in 2015 and combined with OptumRx. Earlier in his career, Mark served as President, CEO and Chairman of SXC Health Solutions, which merged with Catalyst Health Solutions to create Catamaran. During his time as CEO of SXC Health Solutions, the company posted a compound annual growth rate of 50 percent and had a 50-fold increase in shareholder value. Prior to this, Mark led Physicians Interactive, a division of Allscripts Healthcare Solutions, Inc., as President. He spent 10 years with CaremarkRx (now CVS Caremark) as a Corporate Officer and Senior Vice President, Industry Relations. Before joining Caremark, he spent 10 years at IBM in various sales management positions in its health industry division.
Mark holds a Bachelor of Science degree in Finance from the University of Minnesota, a Master’s in Business Administration from Nova Southeastern University and has earned the Certified Employee Benefits Specialist (CEBS) designation.
Faruk Capan
Founder, EVERSANA INTOUCH & Chief Innovation Officer, EVERSANA
Faruk is EVERSANA’s Chief Innovation Officer and the founder of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,800 employees globally that joined EVERSANA in December 2021. Faruk leads the agency team to drive next-generation ideas and strategies for clients across the pharmaceutical and life science industries. He is a graduate of Marmara University and holds a Master of Business Administration from the University of Central Missouri.
Stuart Diamond
Chief Financial Officer
Stuart leads EVERSANA’s financial operations across the globe. An accomplished financial executive with a record of accelerating growth, optimizing operations, and leading transformation across global organizations for more than three decades, he has served as CFO of three public companies and audit chair of two others. Most recently, he was Chief Financial Officer at WPP Media, a global media investment group. He holds a Bachelor of Science in Accounting from the State University of New York at Buffalo and a Master of Business Administration from Fordham University.
Mike Guarino
Chief Executive Officer, EVERSANA INTOUCH
As CEO of EVERSANA INTOUCH, Mike leads the agency’s strategy and operations to help life sciences companies modernize commercialization and unlock growth. A proven industry leader, Mike brings decades of experience building, scaling, and transforming global healthcare marketing organizations. Prior to EVERSANA, he served as Chief Commercial Officer at IPG Health, helping shape one of the world’s largest healthcare communications networks into a $1B+ enterprise. Earlier in his career, he held executive leadership roles at FCB Health and co-founded AREA 23, setting it on its trajectory as one of the industry’s most highly regarded agencies.
He has advised CEOs, CFOs, and Boards on growth strategy, transformation, and organizational design, and is recognized for building communities of exceptional talent that consistently outperform. Mike holds a Bachelor of Science in Comprehensive Science from Villanova University, with a concentration in Business Management.
Jen Norton
President, Market Access & Value, EVERSANA
Jen leads EVERSANA’s market access, pricing, and reimbursement strategies, helping life sciences innovators overcome barriers to drug access and affordability. With more than two decades of leadership in the pharmaceutical market access landscape, Jen brings deep therapeutic expertise across specialty products, biosimilars, oncology, and rare diseases. Prior to EVERSANA, she served as Senior Vice President of US Patient and Market Access at Takeda Pharmaceuticals and Vice President and Head of US Value and Access at Amgen, where she led critical payer negotiations and patient support organizations. She is an active industry leader, currently serving as the 2025 Board Chair for the National Pharmaceutical Council (NPC), and is a dedicated volunteer for community food nonprofits across the country.
Mark Halloran
Senior Vice President & Chief Information Officer
Mark leads EVERSANA’s Information Technology systems and strategies. He brings more than 30 years of healthcare and Prescription Benefit Management business experience to the company, including executive roles at Medco, OptumRx, Zelis Healthcare, United Healthcare, and most recently, Waltz Health. His prior leadership roles and responsibilities have included driving technology transformation and leading the adoption of advanced technologies as required to support both clients and their membership.
Brian Laird
President, Patient Services
Brian oversees EVERSANA’s growing Patient Services team, where he leads efforts to simplify care, improve access, and lower costs by delivering innovative, patient-centered therapy access solutions. With over 25 years of experience across pharmacy operations, clinical services, product development, and marketing, he brings a deep commitment to innovation and growth. Beginning his career as a pharmacist in ambulatory care, Brian’s patient-first approach continues to shape his strategic leadership. He has held executive roles at OptumRx and HealthDyne, where he drove specialty pharmacy expansion and tech-enabled patient service delivery. Brian holds a Pharmacy Degree from the University of Mississippi School of Pharmacy and a Masters Degree in Pharmacy Outcomes and Policy from the University of Florida.
Connie Ingaunti
Executive Vice President, Chief Data Officer
Connie leads EVERSANA’s global data strategy, advancing the integration, activation and commercialization of data across the enterprise. She is a senior healthcare executive with extensive experience across healthcare data, commercialization, patient services and technology-enabled businesses, with a proven track record of leading complex organizations through growth and change. Prior to EVERSANA, Connie was President of Symphony Health, where she drove strategy, operations, financial performance and customer relationships, with a focus on driving growth, operational efficiency and long-term value creation. Previously, she held executive leadership roles as Chief Data Officer at Asembia, and President & COO of Business One Technologies. Connie holds a Bachelor of Science in Pharmacy from St. John’s University and is a Registered Pharmacist.
Jot Chahal
Executive Vice President, Chief AI and Transformation Officer
Jot leads enterprise AI and transformation initiatives at EVERSANA, working across its businesses to accelerate the transformation of the pharmaceutical commercial model. His focus is on translating AI capabilities into connected workflows, stronger customer outcomes, and measurable business value. Before joining EVERSANA, Jot served as Vice President, Global Digital Health at Johnson & Johnson Innovative Medicine. He aligned digital health investments with therapeutic area priorities and emerging technologies, advancing adoption across clinical and commercial settings. He also co-led the AI Strategy workstream for the Johnson & Johnson Enterprise AI Council. Jot also previously held leadership roles at Philips, Mylan and Alcoa. Jot holds an Executive MBA from the MIT Sloan School of Management and a master’s degree in engineering from the University of Michigan. He has also served as a guest lecturer at the Wharton School.
Vikram Anand
President, Compliance Services
Vikram leads EVERSANA’s Compliance Service service line. His experiences include more than 20 years of leading global teams and building successful partnerships with top life sciences companies and health authorities around the globe. His team includes Medical Communications, Pharmacovigilance, Product and Medical Information Contact Center, and Regulatory & Quality Consulting/Outsourcing Services. He holds a Bachelor in Science Degree in Pharmacy from Punjabi University, a Master of Business Administration from Manipal University, and Post Graduate Diploma in Digital Strategies & Transformation from Columbia Business School/MIT Sloan.
Krista Pinto
President, Deployment Solutions
With more than 25 years of experience in the pharmaceutical industry, Krista leads EVERSANA’s Deployment Solutions service line. Propelled with power of data, analytics and digital technology, Krista is transforming the strategy, activation and impact of field-based commercial, medical and market access teams to drive stronger program performance for therapies worldwide. Recently recognized as a MM&M Hall of Femme Honoree and a two-time Rising Star by the Healthcare Businesswoman’s Association, Krista holds a Bachelor’s Degree from the University of Delaware.
Danny Williams
President, Channel Management & 3PL
Danny leads EVERSANA’s Channel Management service line. He brings more than 20 years of experience leading teams to excel in commercial aspects of the pharmaceutical and services industries. His team helps to efficiently deliver therapies to patients, ensure regulatory compliance, and support medical information and pharmacovigilance. Danny is a graduate of the University of Mississippi, and holds a Master of Business Administration from Mississippi College.
Deanna Horner
Executive Vice President, Access Innovation
Deanna helps payers and life sciences partners improve access, affordability, and patient outcomes across the pharmacy ecosystem. An experienced healthcare executive, Deanna is known for driving operational excellence, growth, and meaningful change at the intersection of pharmacy, technology, and patient care. Deanna brings deep expertise in pharmacy strategy, payer dynamics, and access solutions, helping organizations translate complex challenges into scalable, patient‑centered outcomes. She’s spent more than seven years in senior clinical roles at UnitedHealthcare before joining Waltz Health and then EVERSANA. She holds a Bachelor of Science Degree from the University of Illinois, and a PharmD degree from the University of California, San Francisco.
Yi Gu
General Manager of Waltz Health
Yi leads Waltz Health, driving strategy, growth, and innovation to help transform how patients access and afford medications. With extensive experience spanning client operations, product management, and marketing, she has built her career around connecting strategy, technology, and customer needs to deliver better healthcare experiences and outcomes. Yi earned a bachelor’s degree from Carleton College and an MBA from Harvard Business School.
Jon Thierer
Chief Product Officer
Jon Thierer leads product strategy and development at EVERSANA. With expertise spanning pharmacoeconomics, healthcare analytics and artificial intelligence, he has built and deployed multiple platforms that support health plans, pharmaceutical manufacturers, and employers in delivering more effective care. Jon held multiple leadership positions at Waltz Health and OptumRx, where he drove product innovation and technology strategy across pharmacy services and payer solutions. He earned a Bachelor of Arts from the Manhattan School of Music and an MBA from the Wharton School of the University of Pennsylvania.
Mike Ryan
President, Europe
Mike leads EVERSANA’s operations in Europe, the Middle East and Africa, and is responsible for accelerating growth throughout the region. He brings more than 25 years of experience to the industry, having held global leadership positions in both clinical development and life sciences software companies. Ryan passionately believes that technology can simplify the development of novel therapies and improve access to treatment. He holds a degree in Industrial Biochemistry from University Limerick and earned his Master of Business Administration from the University College Cork.
Monica Avram
Chief Legal Officer
Monica leads EVERSANA’s Legal and Compliance function. She has more than two decades of experience as a senior legal executive and business leader across top law firms and global companies, including UnitedHealth Group and Elevance Health. Monica brings a proven record of legal leadership through periods of growth, complexity, and transformation, with deep expertise at the intersection of healthcare, law and emerging technologies. Throughout her career, Monica has built high-performing, financially disciplined legal teams, advised executive leadership and boards on enterprise strategy, and guided businesses through complex regulatory and operational landscapes. As Chief Legal Officer, Monica provides strategic leadership that integrates governance, risk, compliance, and operational execution, enabling innovation, supporting enterprise objectives, and driving long-term value. Monica holds a BA in Biology from the University of Missouri-Kansas City and a Juris Doctor from Suffolk University Law School.
Fred Skinner
Chief People Officer
Fred is the Chief Human Resources Officer at EVERSANA and leads the company’s effort to build a thriving culture and earn recognition as a best place to work. With nearly 20 years of experience in the HR industry, Skinner brings a wide array of experience across employee engagement and talent acquisition functions from multiple industries, including consulting, healthcare, software development, diversified manufacturing and automotive. He holds a Master’s Degree from Roosevelt University.
Meghan Parks
Chief Marketing Officer
Meghan Parks leads EVERSANA’s global marketing and communications strategy, driving brand development, market positioning, and initiatives that support commercial growth. With deep experience across healthcare, pharmacy benefits, and life sciences, she brings expertise in translating complex business strategies into compelling market narratives and building high-performing teams. Prior to EVERSANA, Meghan served as Vice President of Marketing at Waltz Health and held leadership roles at OptumRx, spanning brand strategy, customer engagement, and commercial enablement. She holds degrees in International Relations and Spanish from Miami University.